Emvision Medical Devices Ltd (EMV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Emvision Medical Devices Ltd (EMV) has a cash flow conversion efficiency ratio of -0.301x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.94 Million ≈ $-4.20 Million USD) by net assets (AU$19.74 Million ≈ $13.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See EMV net asset quality index to measure how much of total assets are equity-financed.
Emvision Medical Devices Ltd - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Emvision Medical Devices Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check EMV capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Emvision Medical Devices Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Emvision Medical Devices Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Apex Biotechnology Corp
TW:1733
|
0.003x |
|
Lotte Himart
KO:071840
|
-0.002x |
|
Sound Financial Bancorp Inc
NASDAQ:SFBC
|
0.018x |
|
Rafael Holdings, Inc.
NYSE:RFL
|
-0.090x |
|
Lee Ku Ind
KO:025820
|
0.156x |
|
Loop Telecommunication International Inc
TW:3025
|
0.069x |
|
Balyo SA
PA:BALYO
|
-1.908x |
|
Spheria Emerging Companies Ltd
AU:SEC
|
0.041x |
Annual Cash Flow Conversion Efficiency for Emvision Medical Devices Ltd (2018–2025)
The table below shows the annual cash flow conversion efficiency of Emvision Medical Devices Ltd from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see EMV stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$9.28 Million ≈ $6.57 Million |
AU$-7.84 Million ≈ $-5.54 Million |
-0.844x | -160.85% |
| 2024-06-30 | AU$18.52 Million ≈ $13.10 Million |
AU$-5.99 Million ≈ $-4.24 Million |
-0.324x | -298.43% |
| 2023-06-30 | AU$5.12 Million ≈ $3.62 Million |
AU$834.15K ≈ $590.22K |
0.163x | +130.53% |
| 2022-06-30 | AU$7.08 Million ≈ $5.01 Million |
AU$-3.78 Million ≈ $-2.68 Million |
-0.534x | -19.47% |
| 2021-06-30 | AU$10.05 Million ≈ $7.11 Million |
AU$-4.49 Million ≈ $-3.18 Million |
-0.447x | +24.14% |
| 2020-06-30 | AU$5.52 Million ≈ $3.91 Million |
AU$-3.26 Million ≈ $-2.30 Million |
-0.589x | -22.46% |
| 2019-06-30 | AU$4.60 Million ≈ $3.26 Million |
AU$-2.22 Million ≈ $-1.57 Million |
-0.481x | +9.42% |
| 2018-06-30 | AU$1.28 Million ≈ $905.05K |
AU$-679.59K ≈ $-480.85K |
-0.531x | -- |
About Emvision Medical Devices Ltd
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospita… Read more